| 时明涛.自体动静脉内瘘和人造血管内瘘在维持性血液透析病人的应用对比及安全性分析[J].安徽医药,2021,25(11):2248-2251. |
| 自体动静脉内瘘和人造血管内瘘在维持性血液透析病人的应用对比及安全性分析 |
| Application comparison and safety analysis of autogenous arteriovenous fistula and arteriovenous graft-fistula in patients with MHD |
| |
| DOI：10.3969/j.issn.1009-6469.2021.11.029 |
| 中文关键词: 肾透析 动静脉瘘 自体动静脉内瘘 人造血管内瘘 |
| 英文关键词: Renal dialysis Arteriovenous fistula Autologous arteriovenous fistula Arteriovenous graft-fistula |
| 基金项目: |
|
| 摘要点击次数: 1113 |
| 全文下载次数: 505 |
| 中文摘要: |
| 目的分析自体动静脉内瘘( AVF)和人造血管内瘘( AVG)在维持性血液透析( MHD)病人的应用对比及安全性。方 |
| 英文摘要: |
| Objective To analyze the application and safety of autologous arteriovenous fistula (AVF) and arteriovenous graft-fistula (AVG) in patients with maintenance hemodialysis (MHD).Methods A retrospective analysis was performed on 81 patients with MHDin Nanyang Central Hospital from January 2014 to January 2016 were selected, and the patients were assigned into AVF group (n=46, AVF treatment) and AVG group (n=35, AVG treatment) according to the treatment methods. The first patency rate and re-patency rateof vascular pathway, median survival time of vascular pathway and occurrence of complications were compared between the two groups.Results The first patency rate of vascular pathway in AVF group was significantly higher than that in AVG group (80.43% vs. 37.14% in 6 month, 65.22% vs. 11.43% in 12 month, 28.26% vs. 5.71% in 24 month, 19.57% vs. 2.86% in 36 month, all P<0.05). There was no significant difference in the re-patency rate of vascular pathway in AVF group compared with the AVG group (P>0.05). Median survivaltime of vascular pathway was 39.344 months in AVF group and was 26.273 months in AVG group, and there was no significant difference between the two groups (P>0.05). The incidence rates of complications of vascular stenosis, thrombosis and infection complications in AVF group were lower than those in AVG group, the difference was statistically significant between the two group (P<0.05), and the incidence rates of hemangioma, subcutaneous hematoma, seroma and errhysis were not significantly significant (P>0.05).Con? clusions In the treatment of MHD with AVF, the first patency rate of vascular pathway is higher than that of AVG, the incidence ratesof vascular stenosis, thrombosis and infection is lower than that of AVG, and the safety is better. But there are no significant differencesin the re-patency rate and median survival time of vascular pathway between the two surgical methods. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
